CD95 and CD95-ligand expression in endocrine pancreas of NOD, NOR and BBLB/c mice

被引:24
作者
Signore, A
Annovazzi, A
Procaccini, E
Beales, PE
Spencer, J
Testi, R
Ruberti, G
机构
[1] UNIV ROMA LA SAPIENZA,MED CLIN 2,NUMED GRP,ROME,ITALY
[2] ST BARTHOLOMEWS HOSP,DEPT DIABETES & METAB,LONDON,ENGLAND
[3] UMDS,ST THOMAS HOSP,LONDON,ENGLAND
[4] UNIV ROMA TOR VERGATA,DIPARTIMENTO MED SPERIMENTALE,ROME,ITALY
[5] CNR,INST CELL BIOL,DEPT IMMUNOBIOL,ROME,ITALY
关键词
apoptosis; CD95; CD95L; NOD mouse;
D O I
10.1007/s001250050852
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The non-obese diabetic (NOD) mouse is widely used to study the pathogenesis of insulin-dependent diabetes mellitus, However, the mechanisms responsible for beta-cell destruction, in this model, are still poorly defined. The CD95/CD95L system among other effector systems has been implicated in beta-cell death, In this study we investigated in NOD, non-obese resistant (NOR) and Balb/c mice the expression of CD95 and CD95L in alpha and beta pancreatic cells by immunohistochemistry and immunofluorescence. We demonstrate that alpha cells in the islets of Langherans constitutively express CD95L forming a natural shield around beta cells.
引用
收藏
页码:1476 / 1479
页数:4
相关论文
共 10 条
  • [1] A ROLE FOR CD95 LIGAND IN PREVENTING GRAFT-REJECTION
    BELLGRAU, D
    GOLD, D
    SELAWRY, H
    MOORE, J
    FRANZUSOFF, A
    DUKE, RC
    [J]. NATURE, 1995, 377 (6550) : 630 - 632
  • [2] Cell death mediators in autoimmune diabetes - No shortage of suspects
    Benoist, C
    Mathis, D
    [J]. CELL, 1997, 89 (01) : 1 - 3
  • [3] The role of Fas in autoimmune diabetes
    Chervonsky, AV
    Wang, Y
    Wong, FS
    Visintin, I
    Flavell, RA
    Janeway, CA
    Matis, LA
    [J]. CELL, 1997, 89 (01) : 17 - 24
  • [4] Potential involvement of fas and its ligand in the pathogenesis of Hashimoto's thyroiditis
    Giordano, C
    Stassi, G
    DeMaria, R
    Todaro, M
    Richiusa, P
    Papoff, G
    Ruberti, G
    Bagnasco, M
    Testi, R
    Galluzzo, A
    [J]. SCIENCE, 1997, 275 (5302) : 960 - 963
  • [5] FAS LIGAND-INDUCED APOPTOSIS AS A MECHANISM OF IMMUNE PRIVILEGE
    GRIFFITH, TS
    BRUNNER, T
    FLETCHER, SM
    GREEN, DR
    FERGUSON, TA
    [J]. SCIENCE, 1995, 270 (5239) : 1189 - 1192
  • [6] Fas ligand expression in islets of Langerhans does not confer immune privilege and instead targets them for rapid destruction
    Kang, SM
    Schneider, DB
    Lin, ZH
    Hanahan, D
    Dichek, DA
    Stock, PG
    Baekkeskov, S
    [J]. NATURE MEDICINE, 1997, 3 (07) : 738 - 743
  • [7] Prevention of islet allograft rejection with engineered myoblasts expressing FasL in mice
    Lau, HT
    Yu, M
    Fontana, A
    Stoeckert, CJ
    [J]. SCIENCE, 1996, 273 (5271) : 109 - 112
  • [8] Apoptosis by death factor
    Nagata, S
    [J]. CELL, 1997, 88 (03) : 355 - 365
  • [9] THE NATURAL-HISTORY OF LYMPHOCYTE SUBSETS INFILTRATING THE PANCREAS OF NOD MICE
    SIGNORE, A
    POZZILLI, P
    GALE, EAM
    ANDREANI, D
    BEVERLEY, PCL
    [J]. DIABETOLOGIA, 1989, 32 (05) : 282 - 289
  • [10] STASSI G, 1995, TRANSPLANT P, V27, P1949